Literature DB >> 30566322

Zingerone Nanotetramer Strengthened the Polypharmacological Efficacy of Zingerone on Human Hepatoma Cell Lines.

Mei-Lang Kung, Pei-Ying Lin, Shih-Tsung Huang1, Ming-Hong Tai1, Shu-Ling Hsieh2, Chih-Chung Wu3, Bi-Wen Yeh, Wen-Jeng Wu, Shuchen Hsieh.   

Abstract

We base this study on the concept of drug repositioning to reconstitute the natural product of zingerone as zingerone nanoparticles (zingerone NPs) through a one-pot synthesized process. The as-fabricated zingerone NPs were characterized; they possessed a particle size of 1.42 ± 0.67 nm and a reconstituted structure of zingerone nanotetramer. We further validate the effects of zingerone NPs on the antitumor activity and investigate the relative underlying mechanisms on the human hepatoma SK-Hep-1 and Huh7 cell lines. Our results demonstrated that zingerone NPs significantly inhibit Akt activity and NFκB expression as well as activate the caspases cascade signaling pathway which are involved in the antiproliferation, antitumorigenicity, disturbing cell cycle progression, and induction of DNA damage as well as cell apoptosis. These findings were promising to provide a "Nano-chemoprevention" strategy in future cancer therapeutics and medical and clinical applications.

Entities:  

Keywords:  chemoprevention; human hepatoma cells; nanotetramer; polypharmacological efficacy; zingerone nanoparticles

Mesh:

Substances:

Year:  2018        PMID: 30566322     DOI: 10.1021/acsami.8b14559

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  1 in total

1.  Phytochemically Derived Zingerone Nanoparticles Inhibit Cell Proliferation, Invasion and Metastasis in Human Oral Squamous Cell Carcinoma.

Authors:  Cheng-Mei Yang; Tian-Huei Chu; Kuo-Wang Tsai; Shuchen Hsieh; Mei-Lang Kung
Journal:  Biomedicines       Date:  2022-01-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.